SPRY – Ars Pharmaceuticals Inc
Investors holding2
Combined shares1,045,895
Combined reported value$4.5M
SPRY chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Daniel Loeb | 0.10 | 1,000,000 | $4.3M | Q3 2026 | |
| Paul Tudor Jones narrow view | 0.00 | 45,895 | $198K | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | New | 45,895 | 0.00 |
| Q1 2026 | Daniel Loeb | Added 79.8% | 1,000,000 | 0.17 |
| Q4 2025 | Daniel Loeb | New | 556,237 | 0.09 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Paul Tudor Jones narrow view | New | 45,895 | 0.00 |
| Q1 2026 | Daniel Loeb | Added 79.8% | 1,000,000 | 0.17 |
| Q4 2025 | Daniel Loeb | New | 556,237 | 0.09 |
Reduced: reduced or closed
No tracked investor reduced or closed this position in the last 4 quarters.
History
2 peakQ3 2026: 2 tracked investors
20242026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Daniel Loeb | 1.00M | 1.00M | 1.00M | 556.2K | – | – | – | – |
| Paul Tudor Jones | 45.9K | 45.9K | – | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).